DEUTSCHE BANK AG\ - CAN-FITE BIOPHARMA LTD ownership

CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 6 filers reported holding CAN-FITE BIOPHARMA LTD in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CAN-FITE BIOPHARMA LTD
ValueSharesWeighting
Q1 2015$16,000
-96.1%
7,476
-93.6%
0.00%
Q4 2014$409,000
+7.1%
117,0000.0%0.00%
Q3 2014$382,000
-8.4%
117,0000.0%0.00%
Q2 2014$417,000
-29.0%
117,0000.0%0.00%
Q1 2014$587,000117,0000.00%
Other shareholders
CAN-FITE BIOPHARMA LTD shareholders Q1 2014
NameSharesValueWeighting ↓
TAYLOR ASSET MANAGEMENT INC 796,500$1,346,0000.43%
Virtu Financial LLC 11,169$19,0000.00%
Psagot Value Holdings Ltd. 13,891$23,0000.00%
Citadel Advisors 11,657$20,0000.00%
MORGAN STANLEY 41,600$70,0000.00%
RAYMOND JAMES & ASSOCIATES 12,200$21,0000.00%
UBS Group AG 1,314$2,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 1,200$2,0000.00%
View complete list of CAN-FITE BIOPHARMA LTD shareholders